Invirsa
invirsa.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$17.6M
6 rounds on record
Latest round
$2.9M
Venture round · Jul 2025 · 14 mo ago
Team
7
US Form 5500 (plan participants) · Dec 2025 · 0% in a year
Backers
2
Rev1 Ventures, Ohio Innovation Fund
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 22, 2025
Raised a round Venture round $2.9M · SEC Form D
Nov 14, 2023
Raised a round Venture round $1000k · SEC Form D
Jun 14, 2023
Raised a round Series B $7.7M · led by CincyTech · businesswire
Dec 21, 2022
Raised a round Venture round $6M · SEC Form D
Nov 12, 2020
Raised a round Venture round $40k · SEC Form D
Nov 7, 2017
Raised a round Seed
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2025 | $2.9M | — | SEC Form D |
| Venture round | Nov 2023 | $1000k | — | SEC Form D |
| Series B | Jun 2023 | $7.7M | CincyTech lead | businesswire |
| Venture round | Dec 2022 | $6M | — | SEC Form D |
| Venture round | Nov 2020 | $40k | — | SEC Form D |
| Seed | Nov 2017 | — | — | businesswire.com |
Registers and programsofficial lists and records that name the company
| Legal entity | Invirsa, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Robert ShalwitzExecutive Officer, DirectorSEC Form D
Rachael WingoExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Rev1 Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Built for mission-critical moments and ease of use, Kizen empowers companies to work better, not just faster.
In the harshest conditions on Earth, we discovered a secret to repair UV-induced DNA damage at the molecular level.
3X4 Genetics offers DNA genetic testing that tells you everything you need to know about your body. Learn how to manage your health with…
ゲノム （ DNA ）、エピゲノム、トランスクリプトーム （ RNA ）を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス（ NGS ）／ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
What we do. At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their solubility, stability…
Home About Team Ask Farmako AI Delivering care,24/7 In critical moments, timely access to medicines makes a difference. Farmako delivers…
Overview
Damage control at the DNA level. Invirsa's lead compound (INV-102), quickly and predictably augments the body's response to DNA damage, greatly improving cell stability at the critical moment.
News
Sept 22nd, 2023 Treatment of Sulfur Mustard Corneal Injury by Augmenting the DNA Damage Response (DDR): A Novel Approach
Read more
Report
Invirsa: Clinical-Stage Pharmaceutical Company Secures $7.7 Million
Invirsa - a privately held, clinical-stage pharmaceutical company focused on developing an innovative topically administered eyedrop formulation INV-102 for ocular conditions associated with DNA damage - announced the closing of a $7.7 million Series B fi
Read more
Report
Invirsa Completes $7.7M Series B Financing
Invirsa Inc. has announced the closing of a $7.7 million Series B financing. The financing was led by Ohio-based venture firm, CincyTech.
Read more
Report
Invirsa signs license agreement with AWRI to expand treatment platform for respiratory diseases
Invirsa, a Columbus-based pharmaceutical company, today announced execution of a license agreement with the Abigail Wexner Research Institute (AWRI) at Nationwide Children's Hospital as Invirsa seeks to broaden its treatment platform to address respirator
Read more
Report
Report
People
Robert Shalwitz
Executive Officer, Director
Rachael Wingo
Executive Officer
Faith Voinovich
Director
Bethany George
Director
Michael Venerable
Director
Tim Willis
Director
Wayne Embree
Director
Samuel Lee
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Columbus
United States
HQ
Contact
10-50 est. staff
1275 Kinnear Rd., Columbus, Ohio 43212
Financials
Total raised
$17.6M
Latest round
Venture - Series Unknown
Funding rounds
6